Dr Falk Pharma UK Ltd: UK Public Sector Contracts Won & Awards
Companies House: Private Limited Company·Bourne End, Bucks·Nationwide (UK)·Main market: Pharmaceutical products
Companies House02307698 ↗ · Active
Where they wini
i
22 awards (22 for a named lot, 100%, 0 for a whole procedure with no lot named) · top CPV classes, shares of all 22 awards. An award may cover more than one class.
3360 Pharmaceutical products22 awards · 100% · awards naming a loti
i
Where their buyers arei
i
ITL1 region of the buyer office · known for 19 of 19 awarded procedures · each procedure counts once
Who they sell toi
i
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
NHS & health86%(19 awards)
19 of 22 awards are NHS & health (86%).Type not classified14%(3 awards)
3 of 22 awards are Type not classified (14%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 5 | 26.3% | 5 | 13 Jun 2025 |
| NHS England | 5 | 26.3% | 5 | 8 Apr 2024 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 4 | 21.1% | 10 | 18 Dec 2025 |
| ATAMIS LTD | 2 | 10.5% | 2 | 30 Nov 2021 |
| Regional Business Services Organisation Procurement and Logistics Service | 1 | 5.3% | 2 | 17 Jan 2025 |
| eTenderwales | 1 | 5.3% | 1 | 17 Jun 2025 |
| The NHS Commissioning Board (operating under the name of NHS England) | 1 | 5.3% | 1 | 30 Nov 2021 |
Share = of the 19 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
i
26 of 26 awards carry an end date, 11 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Generic Drugs - Tablets & Capsules | 31 Jan 2027 | £47,800 |
| NP49425 Generic and Biosimilar Transition Medicines | 28 Feb 2027 | £64,103,740 ceiling |
| NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2) | 31 May 2027 | Not published |
| Wave 14c - Orals (plus non-parenteral) Products (all regions) | 31 May 2027 | £1 ceiling |
| Mesalazine Oral/Rectal Preparations | 21 Jun 2027 estimated | £110,204 ceiling |
| Budesonide Oral/Rectal Preparations | 21 Jun 2027 estimated | £45,760 ceiling |
| Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines | 31 Jul 2027 | £3,594,493 ceiling |
| NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 | 30 Apr 2028 | £1 ceiling |
Recent awards
Latest 22 of 22 award records naming this supplier
Other official notice feeds add 4 more procedures won by this supplier. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.
About this data
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
- Contract end dates. Published on 15 of 26 awards, estimated from the published duration on 11 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
- Source. Official UK public procurement notices (Find a Tender, Contracts Finder and Public Contracts Scotland), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses every feed, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.